Avaxim

Avaxim is a vaccine designed to protect against hepatitis A, a viral infection affecting the liver. It contains inactivated hepatitis A virus and algeldrate, administered via intramuscular or subcutaneous injection.

Avaxim is primarily used for the prevention of hepatitis A, a liver infection caused by the hepatitis A virus. This vaccine is recommended for individuals who are at risk of exposure to the virus, such as travelers to regions with high rates of hepatitis A. It is also used for those who have been exposed to the virus and need immediate protection.

Common effects of Avaxim may include soreness or redness at the injection site, mild fever, and general discomfort. These effects are usually mild and temporary, resolving within a few days. Severe reactions are rare but can occur, and medical attention should be sought if symptoms persist or worsen.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Avaxim may interact with certain medications or health conditions. It is advisable to consult a healthcare provider before receiving the vaccine if you are taking immunosuppressants or have a weakened immune system. Alcohol and other substances that affect the immune system may also influence the vaccine's effectiveness.